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Abstract
Background: Asthma and allergy represent complex phenotypes, which disproportionately burden ethnic
minorities in the United States. Strong evidence for genomic factors predisposing subjects to asthma/allergy is
available. However, methods to utilize this information to identify high risk groups are variable and replication of
genetic associations in African Americans is warranted.
Methods: We evaluated 41 single nucleotide polymorphisms (SNP) and a deletion corresponding to 11 genes
demonstrating association with asthma in the literature, for association with asthma, atopy, testing positive for
food allergens, eosinophilia, and total serum IgE among 141 African American children living in Detroit, Michigan.
Independent SNP and haplotype associations were investigated for association with each trait, and subsequently
assessed in concert using a genetic risk score (GRS).
Results: Statistically significant associations with asthma were observed for SNPs in GSTM1, MS4A2, and GSTP1
genes, after correction for multiple testing. Chromosome 11 haplotype CTACGAGGCC (corresponding to MS4A2
rs574700, rs1441586, rs556917, rs502581, rs502419 and GSTP1 rs6591256, rs17593068, rs1695, rs1871042, rs947895)
was associated with a nearly five-fold increase in the odds of asthma (Odds Ratio (OR) = 4.8, p = 0.007). The GRS
was significantly associated with a higher odds of asthma (OR = 1.61, 95% Confidence Interval = 1.21, 2.13;
p = 0.001).
Conclusions: Variation in genes associated with asthma in predominantly non-African ethnic groups contributed
to increased odds of asthma in this African American study population. Evaluating all significant variants in concert
helped to identify the highest risk subset of this group.
Background
Asthma is a complex chronic disease of the airway, with
notable airflow obstruction, eosinophilic inflammation,
bronchoconstriction, and mucus hypersecretion [1].
Asthma and allergy (asthma/allergy) disproportionately
burden ethnic minority children in the United States,
African Americans in particular [2-4]. Asthmatic indivi-
duals of African ancestry have also been characterized
with higher IgE levels, higher dependence on treatment,
and experience more severe clinical symptoms compared
to Whites [2]. Socioeconomic and environmental factors
likely contribute to this disparity, but biological influ-
ences may play a discerning role.
Evidence exists for genomic features contributing to
asthma pathogenesis, which in part relates to innate
immunological characteristics such as variation in host
defense genes [5]. As conveyed in Peden DB 2002, with
rapid urbanization over the last few decades, some scien-
t i s t sb e l i e v et h a tg e n e sp r e v i o u s l yp r o t e c t i n gh u m a n s
from parasitic infection may now contribute to a ‘misdir-
ected’ response to environmental agents [6]. Individuals
residing in lower socioeconomic urban environments
may experience a higher burden of environmental risk
factors for allergy or asthma. Thus, evaluating genetic
* Correspondence: brjoubert@gmail.com
1US Environmental Protection Agency (EPA), National Exposure Research
Laboratory, Durham, NC, USA
Full list of author information is available at the end of the article
Joubert et al. BMC Medical Genetics 2011, 12:25
http://www.biomedcentral.com/1471-2350/12/25
© 2011 Joubert et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.susceptibility to asthma/allergy in such vulnerable popu-
lations can help to direct public health prevention and
treatment efforts.
A variety of review papers describe genes associated with
allergy/asthma [6-10]. Ober et al. [7] list genes associated
with asthma or atopy in more than 10 studies. This study
evaluated 8 of these genes (IL4, IL13, TNF-a, HLA-DRB1,
HLA-DQB1, FCER1B/MS4A2, CD14, ADAM33)a sw e l la s
3 glutathione-s-transferase genes (GSTM1, GSTP1,a n d
GSTT1) for association with asthma/allergy among urban-
residing African Americans. We note some key aspects of
the biological significance of the genes evaluated.
Many of these genes play roles in the Th2 response to
antigens, airway reactivity, or non-specific modulation of
inflammation [6]. The Th2 response is more characteris-
tic of asthma in children compared to adults [6,11] and
typically accompanied by elevated immunoglobulin E
(IgE) response to allergen [12]. Genes within the chro-
mosome 5q cytokine cluster have demonstrated strong
associations with asthma/allergy, most notably for IL4
and IL13 [2,7,13-17]. Associations with total serum IgE
have also been observed, but with variable findings
across ethnicity [18]. Also located on chromosome 5,
t h eC - 1 5 9 Ts i n g l en u c l e o t i d ep o l y m o r p h i s m( S N P )
within the cluster of differentiation (CD14)g e n eh a s
been associated with asthma, asthma severity [16,19],
and total serum IgE [20,21]. The CD14 cell surface
receptor mediates host interactions with endotoxin [11],
suggesting a role in response to environmental stress.
Another gene encoding a proinflammatory cytokine is
tumor necrosis factor alpha (TNF-a), which has been
associated with eosinophilic inflammation during lower
respiratory tract infection with respiratory syncytial
virus (RSV) in children [22].
Relevant to airway reactivity, a disintegrin and metal-
loprotease 33 (ADAM33) is expressed in bronchial tissue
and whole lung [23,24]. ADAM33 SNPs have been asso-
ciated with airway remodeling and bronchial hyper-
responsiveness [25], but have varying associations with
asthma/allergy and total serum IgE across ethnic popu-
lations [16,23,26].
Human Leukocyte Antigen (HLA) class II genes relate
to non-specific modulation of inflammation. HLA-DRB1
and HLA-DQB1 SNPs and haplotypes have been asso-
ciated with a higher risk of toluene diisocyanate-induced
occupational asthma [27], total serum IgE in Iranian
subjects [28], atopy in Northern Chinese [29], Dermato-
phagoides Spp.-sensitive asthma in Venuezuelan indivi-
duals [30], and asthma severity in Whites in the United
States [31], suggesting a broad role for these genes in
asthma pathogenesis across ethnic groups.
The high affinity multimeric surface receptor for IgE
(Fcepsilon R1beta) is essential for IgE-mediated acute
allergic response, and is thereby relevant for asthma
pathogenesis [32]. Altered transcription of FcepsilonRl-
beta correlates to the MS4A2 membrane-spanning
4-domains, subfamily A, member 2 (MS4A2), also
known as “Fc fragment of IgE, high affinity I, receptor
for beta polypeptide (FCER1B)”. MS4A2 SNPs and hap-
lotypes have been associated with asthma in various
populations [33-35].
Outside of the host immune response framework are
the glutathione S-transferase (GST) genes, a superfamily
of genes that catalyze the conjugation of reduced glu-
tathione to electrophilic and hydrophobic compounds
[36]. The conjugation of glutathione is important for the
metabolism or detoxification of therapeutic drugs, envir-
onmental toxins, and products of oxidative stress, rele-
vant to asthma [37,38]. A recent meta-analysis of GST
genes and asthma phenotypes reported that GSTM1 and
GSTT1 showed increased asthma risk associated with the
null genotype but that heterogeneity across studies and
publication bias was a major limitation [39]. In this
paper, we consider key asthma candidate genes for asso-
ciation with asthma and allergy phenotypes among Afri-
can American children living in Detroit, Michigan.
Methods
Study population and measurements
This study involved participants of the Mechanistic Indi-
cators of Asthma (MICA) study, conducted by the United
States Environmental Protection Agency between
November 2006 and January 2007 in Detroit, Michigan,
as previously described [40,41]. This was a cross-sectional
study based on a stratified sample of children using two
strata: children with asthma and children without
asthma, selected in an approximately 1:1 ratio. A total of
205 children age 9-13 years old participated in the clini-
cal study. In order to reduce the genetic heterogeneity of
subjects in our analysis, while maximizing the total num-
ber of subjects studied, only African American children
(N = 141) were selected for analysis. The study design
and protocols were approved by the Institutional Review
Boards at Henry Ford Health System (Detroit, MI),
Westat Inc. (Rockville, MD), and the University of North
Carolina at Chapel Hill (Chapel Hill, NC - US EPA’sI R B
of record). Written consent was obtained from guardians,
and written assent was obtained from each child, with an
oral review of both consent and assent prior to study
enrollment.
For the analyses presented in this paper, hospital
records were evaluated to determine doctor diagnosis of
asthma for each study participant. To verify genetic asso-
ciations with doctor diagnosis, two additional variables
were created based on parental questionnaire data: cur-
rent asthma (yes/no), and medication use (yes/no). Cur-
rent asthma was defined based on the question “Have
you had an asthma attack within the last 12 months?”
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asthma medication use.
Allergy-related traits were considered as separate phe-
notypes. This included total serum IgE, allergen-specific
IgE (Phadiatop), testing positive for food allergens based
on IgE levels, and absolute eosinophils. Total IgE was
measured in serum samples using the ImmunoCAP 250
autoanalyzer (Phadia, Portage, MI, USA). Allergen speci-
fic IgE was measured in serum using a multi-allergen
screen, which detects the presence (positive/negative)
and relative level of antibody specific IgE for a panel of
at least 15 common aeroallergens expressed as the Pha-
diatop level. The food allergen screening test included
the 6 most common allergy-provoking foods according
to the Food and Drug Administration: cows’sm i l kp r o -
tein, egg white, wheat, codfish, peanut, and soybean.
Eosinophil antibodies were measured in blood samples
collected from nonfasting children using standard meth-
ods as mandated by Clinical Laboratory Improvement
Amendments (CLIA).
Genotyping
A total of 53 SNPs were selected for genotyping. The can-
didate SNPs for this study were selected based upon: 1) a
literature search for gene regions having multiple, inde-
pendently-replicated associations with asthma, 2) pub-
lished variability within African ancestry populations, 3)
minimal evidence of LD within African ancestry popula-
tions, and 4) methodological considerations. For the first
criterion, the primary source for the original SNP search
was Ober et al., 2006 [7]. For the second criterion, the
SNPs were selected by querying NCBI databases for poly-
morphisms with minor allele frequency > 10% in African
ancestry samples. This was done because approximately
85% of the individuals in the MICA study are African
American, only African Americans were analyzed in this
report, and as noted in Chang et al. 2009 [42], African
ancestry groups have substantially different allele frequen-
cies compared to Whites for some variants. For the third
criterion, although we aimed to select SNPs with as little
LD as possible, this could not be obtained for all of the
genes evaluated. For the fourth criterion, implemented
due to methodological considerations of the available gen-
otyping technology, we preferentially chose SNPs within
regions of low surrounding SNP density. This fourth cri-
terion was necessary for the HLA gene regions.
Total genomic DNA was isolated from white blood
cell pellets using the QiagenFlexiGene DNA kit (Qiagen,
Valencia, CA). Additionally, blood clot samples were
homogenized using a PowerGen 125 homogenizer
(Fisher Scientific, Waltham, MA) and total gDNA was
isolated from the homogenate using the QiagenFlexi-
Gene DNA kit. Quantitation of gDNA for each sample
was performed using the Nanodrop-1000 (Nanodrop
Technologies, Wilmington, DE). Pre-Designed Taq-
ManSNP Genotyping Assay, Custom TaqMan SNP Gen-
otyping Assay or TaqMan Drug Metabolism Genotyping
Assay (Applied Biosystems, Inc., Foster City, CA) was
selected and designed for each SNP of interest using
manufacturer’s specificity protocol. Custom TaqMan
SNP sequences were submitted via FileBuilder software
(Applied Biosystems, Inc.) for assay design. Pre-
Designed and Custom TaqMan SNP Genotyping Assays
were run with TaqMan Genotyping Master Mix
(Applied Biosystems, Inc.) according to the manufac-
turer suggested cycling conditions. The TaqMan Drug
Metabolism Genotyping Assays were run with TaqMan
Universal PCR Master Mix (Applied Biosystems, Inc.),
also according to the manufacturer suggested cycling
conditions. SNP genotypes were determined using 1.0 -
5.0 ng of gDNA template and suggested master mix on
the ABI PRISM 7900 Sequence Detection System
(Applied Biosystems, Inc.). All SNP PCR runs contained
an internal no-template control in order to determine
the absence of cross contamination. SNP genotyping
was performed in duplicate for ten percent of the DNA
samples as a quality control measure to ensure identical
genotypes between identical samples. Mismatched geno-
types were run a third time to resolve discrepancies.
SNPs missing more than 3% of genotype results and
individuals missing more than 10% of their data were
excluded from further analyses. Remaining SNPs were
tested for consistency with Hardy-Weinberg Equilibrium
(HWE) among non-asthmatics using a threshold p-value
of 0.001. Statistical quality control was completed using
PLINK version 1.06 [43,44].
Statistical analysis
Continuous outcomes (total serum IgE, Phadiatop, food
allergen-specific IgE, and eosinophils) were log-trans-
formed and assessed for normal distribution using the
Shapiro-Wilk test. Log-transformed Phadiatop, food
allergen-specific IgE, and eosinophils did not approxi-
mate normal distribution and were evaluated as the
dichotomous terms based on clinical cut-points used in
other studies. Specifically, subjects with Phadiatop values
≥ 0.35 kIU/L were designated as atopic [41]; subjects
with food allergen-specific IgE ≥ 0.35 kIU/L were classi-
fied as having tested positive for a panel of food aller-
gens [45]; and subjects with absolute eosinophils ≥ 0.40
K/uL were categorized as having eosinophilia.
The association between each variant and asthma/
allergy was evaluated through linear regression for con-
tinuous dependent variables (total serum IgE) or logistic
regression for dichotomous dependent variables (asthma,
atopy, testing positive for food allergens, and eosinophi-
lia), following an additive genetic model. False discovery
rate (FDR) was employed to correct for multiple testing
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FDR where the association was considered significant.
Analyses were completed using PLINK [43,44] and R ver-
sion 2.12.0 [47]. Linkage disequilibrium (LD) across
SNPs was examined for each chromosome or gene in
Haploview version 4.1 [48]. For perspective, genotyped
SNPs were evaluated for LD with HapMap SNPs from
the individuals of African ancestry from the South West
United States (ASW) population.
Significant SNP associations were followed up with hap-
lotype analyses. SNPs were phased in PLINK [43,44] using
the expectation-maximization (E-M) algorithm to assign
individual haplotypes. Haplotypes were then evaluated for
association with asthma/allergy through linear and logistic
regression. To evaluate the consistency of haplotype esti-
mation and association across software, PHASE version 2.1
[49,50] and Haplostats version 1.4.4 [51] were employed to
estimate haplotype assignments per individual and haplo-
type associations with asthma related traits, respectively.
Haplostats haplo.scan [52] was implemented to identify the
locus or loci within each haplotype demonstrating the
strongest association with a particular trait. All haplotype
analyses were run if the genes had one or more statistically
significant SNP associations with the phenotypes of inter-
est, after correction for multiple testing. FDR was also
applied to the haplotype analyses. Age, sex, body mass
index, and urinary cotinine levels were evaluated for effect
measure modification using the Breslow-Day test of homo-
geneity of effect estimates across covariate categories. Con-
founding was subsequently evaluated using the percent
change in effect estimate criterion [45,53].
In addition to the haplotype analyses, SNP association
analyses were complimented by constructing a genetic
risk score (GRS), using a linear weighting of 0, 1, or 2
for genotypes containing 0, 1, or 2 risk alleles, respec-
tively. For this model only, risk alleles were considered
those that increased the risko fa s t h m ai nt h ei n d e p e n -
dent SNP models. For example, because rs1871042 T
corresponded to a lower risk of asthma, rs1871042 C
was considered the risk allele for the GRS. The purpose
of the GRS was to assess the cumulative effect of the
k e yS N P si no u rs t u d yo nt h eo d d so fa s t h m ai nt h i s
population. A GRS has been used in studies of heart dis-
ease and diabetes using a variety of methods [54-57].
We followed similar methodology to that of a study
describing a GRS to predict type 2 diabetes [58]. The
program Tagger [59] was employed to select a minimal
set of SNPs from each gene. Selected SNPs were consid-
ered independent and equally weighted. The GRS was
tested for normal distribution using the Shapiro-Wilk
normality test and a trend test was applied to evaluate
the linearity of the relationship between the number of
risk alleles and the odds of asthma.
Results
Quality control
Among the 10% of samples run in duplicate, 100%
obtained identical results. A total of 41 of the 53 SNPs
(77%) passed statistical quality control. Association with
asthma/allergy was evaluated for the following genes
(SNPs): GSTM1 (rs17672 C/T, rs412543 G/C, rs3815029
G/C), IL13 (rs1800925 C/T, rs1295686 A/G, rs20541 C/T,
rs848 G/T, rs2069750 G/T), IL4 (rs2070874 C/T, rs734244
G/A, rs2243267 G/C, rs2243270 G/A, rs2243290 C/A),
CD14 (rs2563298 C/A, rs5744456 T/A, rs2569190 G/A,
rs2569191 T/C, rs3138078 G/T), TNF (rs1800629 G/A,
rs3093662 A/G, rs3093664 A/G, rs3093665 A/C,
rs3093668 G/C), HLA-DRB1 (rs9269701 G/A, rs9269743
A/G, rs9269841 G/A), HLA-DQB1 (rs4993986 C/G),
MS4A2 (rs574700 C/T, rs1441586 T/C, rs556917 A/T,
rs502581 C/A, rs502419 G/A), GSTP1 (rs6591256 A/G,
rs17593068 G/T, rs1695 A/G, rs1871042 C/T, rs947895
C/A), ADAM33 (rs2787094 G/C, rs543749 G/T, rs44707
A/C, rs2271511 C/T), and GSTT1 (null vs. present
genotype).
Demographics and phenotypic/genotypic differences by
ethnic group
Among the 141 individuals analyzed, 63 (44.7%) were
female and 51 (36.2%) had a body mass index of 25 or
higher. A total of 64 (49.6%) individuals were asthmatic,
92 (66%) atopic, 54 (39.7%) tested positive for a panel of
food allergens, and 24 (17%) were designated as having
eosinophilia. Of the 53 SNPs subjected to quality con-
trol, 12 SNPs were excluded due to missing > 3% of
genotyping data (N = 7) or failed HWE (N = 5). Infor-
mation on the remaining 41 SNPs and GSTT1 -null var-
iant was available for 141 African American subjects.
The mean total serum IgE was 4.63 kU/L (standard
deviation = 1.62 kU/L). Total serum IgE, atopy, testing
positive for food allergens, and eosinophilia were signifi-
cantly associated with asthma (Table 1) and evaluated as
outcomes in separate statistical models. No effect mea-
sure modification by covariates was observed. Sex was
found to be the only significant confounder in the SNP
and haplotypes models and was included as a covariate.
Table 1 Association between asthma and related traits
Trait OR (95% CI) p
Total serum IgE 1.60 (1.24, 2.07) < 0.0001
Atopy 3.09 (1.39, 6.87) 0.006
Food allergen test positive 2.04 (0.99, 4.20) 0.053
Eosinophilia 3.56 (1.30, 9.73) 0.013
† Logistic regression employed to estimate the Odds Ratio (OR) and 95%
Confidence Interval (CI) of the Odds Ratio; p: p-value.
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The number of subjects analyzed for each phenotype was
129, 138, 136, 140, and 140, for asthma, atopy, testing
positive for food allergy, eosinophilia, and total serum
IgE phenotypes, respectively. Statistically significant asso-
ciations were only observed for the asthma phenotype,
for SNPs in GSTM1, MS4A2,a n dGSTP1, after correc-
tion for multiple testing (Figure 1, Table 2). GSTM1
rs412543 C carriers were almost 3 times as likely to have
asthma compared to individuals without the C allele. All
of the MS4A2 SNPs evaluated were associated with a
lower odds of asthma, and the associations were statisti-
cally significant for rs556917 A/T, rs502581 C/A, and
rs502419 G/A. Strong linkage disequilibrium existed
across MS4A2, in particular for rs556917, rs502581, and
rs502419 (r
2 >0 . 7 ,F i g u r e2 ) .T h et i g h t l yl i n k e dGSTP1
SNPs rs1871042 C/T and rs947865 C/A (Figure 3) were
associated with a lower odds of asthma.
Haplotype associations
The statistically significant SNP associations were com-
plimented by gene-specific haplotype analyses, presented
in Table 3. GSTM1 haplotypes CCG and CGC
corresponding to SNPs rs17672, rs412543, and
rs3815029, showed contrasting direction of associations
with asthma. Specifically, the CCG haplotype was asso-
ciated with a 3 fold increase in the odds of asthma
whereas the CGC haplotype corresponded to an Odds
Ratio (OR) of 0.36. The frequency of both of these hap-
lotypes was approximately 10%. The MS4A2 TCTAA
haplotype offered a protective association with asthma
compared to the CTACG (Table 3). Sliding window
analyses in Haplostats indicated that 3 tightly linked
SNPs (MS4A2-ACG haplotype for rs556917, rs502581,
and rs502419) drove the association with asthma (simu-
lated p values = 0.03, 0.033, 0.026 for rs556917,
rs502581, and rs502419, respectively, 1000 simulations).
GSTP1 AGATA (OR = 0.28, p = 0.027) and GSTP1
AGGCC (OR = 2.23, p = 0.018) displayed contrasting
associations with asthma. Sliding window analyses in
Haplostats identified loci rs1695, rs1871042, and
rs947895 to be the strongest SNPs driving the associa-
tions, based on the maximum scan statistics. However,
the locus-scan statistic p values and max-stat simulated
global p value were not statistically significant (p >0 . 0 5
for 1000 simulations).
Figure 1 Segmented Manhattan plot displaying SNP associations with asthma/allergy traits.N e g a t i v el o g - t r a n s f o r m e dp-value (-log(p))
indicative of statistical significance for the association between each SNP and trait, where higher -log(p) values correspond to greater statistical
significance. SNPs significant based on FDR < 0.25 indicated with a black box.
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Chromosome 11 haplotypes displayed the strongest statis-
tically significant associations with asthma and were subse-
quently evaluated for a chromosome-wide haplotype effect
on asthma. The chromosome 11 haplotype CTAC-
GAGGCC (corresponding to MS4A2 rs574700, rs1441586,
rs556917, rs502581, rs502419 and GSTP1 rs6591256,
rs17593068, rs1695, rs1871042, rs947895) was associated
with a nearly five-fold increase in the odds of asthma (OR
= 4.8, p = 0.007). The frequency of this haplotype was 10%
in our population. At the time this work was conducted,
PLINK software did not include computation of 95% con-
fidence intervals for haplotype associations.
Genetic risk score
SNPs significantly associated with elevated odds of
asthma were evaluated in concert by constructing a
genetic risk score. This score combined data for the fol-
lowing SNPs: GSTM1 rs412543, MS4A2 rs556917 and
rs502419 (tagging rs502581), and GSTP1 rs947895 (tag-
ging rs1871042). The MS4A2 SNPs rs556917 and
rs502419 did not tag each other, and were both included
in the GRS. This was consistent with modified settings
of the Tagger program (data not shown).
The genetic risk score ranged from 0 to 7 variant alleles
carried by an individual and approximated normal distri-
bution (W = 0.98, Z = 1.142, p = 0.126). The GRS was
statistically significantly associated with a higher odds of
asthma (OR = 1.61, 95% Confidence Interval (CI) = 1.21,
2.13; p = 0.001). Incremental increases in the GRS corre-
sponded to higher total serum IgE and higher odds of
atopy and eosinophilia, but these results were not statisti-
cally significant.
Discussion and Conclusion
Genetic associations with asthma
In this study, we evaluated previously identified variants
for association with asthma/allergy among African
American children living in Detroit, Michigan. Of the
41 SNPs evaluated in statistical analyses, SNPs within
GSTM1, MS4A2,a n dGSTP1 were associated with
asthma. Chromosome 11 SNPs, in particular the MS4A2
-CTACG/GSTP1 -AGGCC haplotype, played the great-
est role in genetic predisposition to asthma in this
population. When risk alleles were evaluated in concert
using a genetic risk score, SNPs predisposing individuals
to asthma exhibited an expected cumulative effect. The
genetic risk score (or genetic risk index) has been
employed to understand individual susceptibility to obe-
sity [60], cardiovascular disease [61-63], coronary artery
disease [64], diabetes [58], serum uric acid concentration
[65], multiple sclerosis [66], and rheumatoid arthritis
[67]. Some studies have evaluated a weighted GRS,
where each SNP included in the score is weighted by a
beta coefficient from a meta-analysis of SNPs associated
with disease, as was done in Cornelis et al., 2009 [58].
To our knowledge, a meta-analysis providing sufficient
data for the construction of a GRS for asthma/allergy
was not available at the time these analyses were
completed.
Functional significance and role in asthma etiology
The observation that variation in MS4A2 was signifi-
cantly associated with a higher risk of asthma is consis-
tent with MS4A2’s involvement in allergic disease [32].
SNPs within MS4A2 have previously been associated
with atopy via regulation of Fc epsilon RI expression [68].
Table 2 Association between SNPs and asthma
Gene Chr Position SNP MAF Odds Ratio (95% CI) Unadjusted p FDR
GSTM1 1 108482748 rs17672 C/T 0.16 1.47 (0.71, 3.04) 0.302 0.673
1 110031467 rs412543 G/C 0.12 2.89 (1.14, 7.32) 0.025 0.207
1 110031479 rs3815029 G/C 0.17 0.69 (0.33, 1.42) 0.312 0.673
MS4A2 11 59612059 rs574700 C/T 0.18 0.50 (0.23, 1.07) 0.042 0.249
11 59612604 rs1441586 T/C 0.43 0.56 (0.25, 1.25) 0.114 0.390
11 59615288 rs556917 A/T 0.34 0.47 (0.22, 0.97) 0.028 0.207
11 59616754 rs502581 C/A 0.26 0.50 (0.24, 1.02) 0.030 0.207
11 59622751 rs502419 G/A 0.24 0.45 (0.21, 0.93) 0.028 0.207
GSTP1 11 67106475 rs6591256 A/G 0.43 0.66 (0.31, 1.38) 0.162 0.495
11 67107508 rs17593068 G/T 0.43 0.71 (0.34, 1.50) 0.169 0.495
11 67109265 rs1695 A/G 0.44 1.61 (0.75, 3.42) 0.208 0.569
11 67110420 rs1871042 C/T 0.30 0.44 (0.22, 0.91) 0.010 0.207
11 67110982 rs947895 C/A 0.29 0.44 (0.22, 0.91) 0.015 0.207
† 41 SNPs evaluated as well as the GSTT1 deletion. Logistic regression adjusted for sex and performed in PLINK version 1.06. SNP major allele/minor allele noted,
in that order. MAF: Minor allele frequency; Chr: Chromosome, 95% CI: 95% Confidence Intervals of the odds ratio, p: p-value. Statistical significance after
correction for multiple comparisons evaluated using False Discovery Rate (FDR). FDR ≤ 0.25 denoted statistically significant associations, marked in bold. Data
presented for genes with one or more statistically significant associations. Models included 129 individuals.
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individuals found weak evidence for rs502581 to be asso-
ciated with IgE [69]. We did not identify significant asso-
ciations between this SNP and IgE in our study
population, but we note the direction of effect was con-
sistent with what has been reported, the A allele corre-
sponding to lower IgE levels (b = -0.14, 95% CI = -0.64,
0.36, p = 0.587) and the T allele corresponding to higher
IgE levels. In our study population, the A allele was the
risk allele tested due to default parameters in PLINK.
GSTP1’s role in xenobiotic metabolism and antioxida-
tion is also consistent with asthma etiology, although it
is likely to play a different role in asthma pathogenesis
compared to MS4A2. Variation in this gene may result
in differing metabolism of environmental toxins across
individuals. We speculate that individuals with multiple
risk alleles across MS4A2 and GSTP1 genes are more
susceptible to harmful effects of environmental toxins,
and that this sensitivity may contribute to the develop-
ment of asthma or asthma exacerbation. Additional
Figure 2 Linkage disequilibrium (LD) observed across SNPs of MS4A2.r
2 values displayed in triangle plot represent strength of LD
between SNPs. Color scheme: white (weakest LD): D’ < 1, LOD < 2; blue: D’ = 1, LOD < 2; shades of pink/red: D’ < 1, LOD≠2; bright red
(strongest LD): D’ = 1, LOD≠2. SNPs in study population indicated in green, HapMap SNPs in black. HapMap data specific to the individuals of
African ancestry from the South West United States (ASW) population.
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required to confirm this hypothesis. We did not observe
significant associations between the functional sequence
variant in GSTP1 at codon 15 (Ile105Va - rs1695). The
role of this variant in asthma/allergy has been inconsis-
tently reported in the literature, possibly due to hetero-
geneity of environmental exposures [70]. Other studies
have reported that this variant is tagged by rs947895 in
White populations [71], which corresponded to a signifi-
cant association with asthma in our study. However,
the genetic variation that is tagged by this SNP in our
African ancestry population may be less than what has
been reported in other ethnic groups.
Supporting analyses
Asthma is a complex trait that is variably defined across
studies. Thus, we compared our definition of asthma with
slightly variable phenotypes, current asthma (yes/no) and
asthma medication use (yes/no) based on parental ques-
tionnaire data. The association between SNPs, haplotypes,
or the GRS and asthma was consistent when evaluated for
current asthma or medication use, with regards to the
direction of association (odds ratio estimates) and statisti-
cal significance (p-values).
Limitations
Our study population was largely atopic (67%) and over
39% tested positive for response to a panel of food aller-
gens. These statistics limit the generalizability of our
findings to children of similar age in the United States.
However, the associations discussed here may be infor-
mative for other vulnerable populations or high risk
groups where the prevalence of asthma is high.
The sample size of 141 limited our power to detect
statistically significant associations after correction for
multiple testing. Because of the small number of SNPs
Figure 3 Linkage disequilibrium (LD) observed across SNPs of GSTP1.r
2 values displayed in triangle plot represent strength of LD between
SNPs. Color scheme: white (weakest LD): D’ < 1, LOD < 2; blue: D’ = 1, LOD < 2; shades of pink/red: D’ < 1, LOD≠2; bright red (strongest LD): D’ =
1, LOD≠2. SNPs in study population indicated in green, HapMap SNPs in black. HapMap data specific to the individuals of African ancestry from the
South West United States (ASW) population.
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Page 8 of 11genotyped, we were unable to capture much of the
genomic landscape relevant to the phenotypes of inter-
est. Thus, unmeasured genetic risk factors that play a
role in asthma/allergy susceptibility were inadequately
captured in this study. The small number of SNPs also
limited our ability to comprehensively assess population
stratification through principal components analysis
using genome wide data or ancestry informative markers
(AIMS). We relied on self-reported ethnicity to reduce
issues of genetic heterogeneity. For these reasons, cau-
tion is warranted when assessing the generalizability of
our study findings to other independent cohorts.
The candidate genes were selected for genotyping
before the publication of the DENND1B association with
a s t h m ai nag e n o m ew i d ea s s o c i a t i o ns t u d yo fA f r i c a n -
ancestry populations [72]. DENND1B is expressed by
natural killer cells and dendritic cells, encoding a protein
that interacts with the TNF-a receptor. Although we do
not present data on this gene, we note that significant
associations between the measured TNF-a SNPs and
asthma were not observed in this study population.
Future directions
This report did not incorporate environmental risk fac-
tors for asthma. It is likely that environmental agents
interact with a person’s genetic predisposition or pro-
vide an additional burden on the genetically susceptible
group, increasing the odds of asthma/allergy or exacer-
bating symptoms. Future work should incorporate a
greater number of subjects and SNPs, and evaluate
SNPs and environmental exposures in concert as they
relate to asthma, asthma severity and asthma exacerba-
tion. It remains particularly important to test and vali-
date associations in populations with a high disease
burden.
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Table 3 Association between haplotypes and asthma
Gene Chr BP1 BP2 SNP1 SNP2 Haplotype Frequency Odds Ratio Unadjusted p FDR
GSTM1 1 108482748 110031479 rs17672 rs3815029 CCG 0.10 3.01 0.05 0.210
1 108482748 110031479 rs17672 rs3815029 CGC 0.11 0.36 0.04 0.209
1 108482748 110031479 rs17672 rs3815029 CGG 0.64 0.82 0.506 0.781
1 108482748 110031479 rs17672 rs3815029 TCC 0.01 4.48 0.298 0.626
1 108482748 110031479 rs17672 rs3815029 TGC 0.05 1.58 0.508 0.781
1 108482748 110031479 rs17672 rs3815029 TGG 0.09 1.18 0.759 0.839
11 59612059 59622751 rs574700 rs502419 CCACG 0.08 1.63 0.286 0.626
11 59612059 59622751 rs574700 rs502419 CCTAA 0.07 0.86 0.758 0.839
11 59612059 59622751 rs574700 rs502419 CCTCA 0.01 1.02 0.982 0.982
MS4A2 11 59612059 59622751 rs574700 rs502419 CCTCG 0.07 0.78 0.595 0.781
11 59612059 59622751 rs574700 rs502419 CTACG 0.57 1.58 0.114 0.399
11 59612059 59622751 rs574700 rs502419 TCTAA 0.14 0.43 0.032 0.209
11 59612059 59622751 rs574700 rs502419 TCTAG 0.04 1.04 0.96 0.982
11 67106475 67110982 rs6591256 rs947895 AGACC 0.27 1.2 0.519 0.781
11 67106475 67110982 rs6591256 rs947895 AGATA 0.07 0.28 0.027 0.209
11 67106475 67110982 rs6591256 rs947895 AGATC 0.01 0.56 0.642 0.793
GSTP1 11 67106475 67110982 rs6591256 rs947895 AGGCC 0.21 2.23 0.018 0.209
11 67106475 67110982 rs6591256 rs947895 GTACC 0.18 0.82 0.573 0.781
11 67106475 67110982 rs6591256 rs947895 GTATA 0.02 0.19 0.201 0.603
11 67106475 67110982 rs6591256 rs947895 GTGCC 0.03 1.59 0.562 0.781
11 67106475 67110982 rs6591256 rs947895 GTGTA 0.19 0.70 0.288 0.626
† Logistic regression adjusted for sex and performed in PLINK version 1.06. SNP1: SNP of left-most (5’) SNP in haplotype, SNP2: SNP of right most (3’) SNP in
haplotype. ß: Beta estimate, p: p-value. Statistical significance after correction for multiple comparisons evaluated using False Discovery Rate (FDR). FDR ≤ 0.25
denoted statistically significant associations, marked in bold. Models included 129 individuals.
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